CAPITAL FUND MANAGEMENT S.A.
Institutional investor · Portfolio as of Q1 2020
Top Holdings1,500 positions
Exxon Mobil Corp | 2.1M | $81.1M | 1.3% | — | — | — | Increased — |
SPDR S&P 500 ETF Trust | 294,800 | $76M | 1.2% | — | — | — | Increased — |
Netflix Inc | 200,500 | $75.3M | 1.2% | — | — | — | Increased — |
Tesla Inc | 127,000 | $66.5M | 1.0% | — | — | — | Decreased — |
Merck & Co Inc | 835,422 | $64.3M | 1.0% | $62.45 | -3.97% | 6 qtrssince 2018-Q4 | Increased 67 |
Costco Wholesale Corp | 214,700 | $61.2M | 0.9% | — | — | — | Decreased — |
Amgen Inc | 300,500 | $60.9M | 0.9% | — | — | — | Increased — |
Bristol-Myers Squibb Co | 1M | $56.8M | 0.9% | — | — | — | Increased — |
Bristol-Myers Squibb Co | 1M | $56M | 0.9% | — | — | — | Increased — |
SPDR S&P 500 ETF Trust | 215,300 | $55.5M | 0.9% | — | — | — | Increased — |
CVS Health Corp | 887,100 | $52.6M | 0.8% | — | — | — | Increased — |
Tesla Inc | 98,600 | $51.7M | 0.8% | — | — | — | Decreased — |
Intel Corp | 938,300 | $50.8M | 0.8% | — | — | — | Decreased — |
Netflix Inc | 134,100 | $50.4M | 0.8% | — | — | — | Increased — |
Apple Inc | 193,200 | $49.1M | 0.8% | — | — | — | Decreased — |
Intel Corp | 842,100 | $45.6M | 0.7% | — | — | — | Decreased — |
QUALCOMM Inc | 619,318 | $41.9M | 0.6% | $59.38 | -1.01% | 3 qtrssince 2019-Q3 | Increased 66 |
Shopify Inc | 98,200 | $40.9M | 0.6% | — | — | — | Decreased — |
CVS Health Corp | 689,600 | $40.9M | 0.6% | — | — | — | Decreased — |
Exxon Mobil Corp | 1M | $39.5M | 0.6% | — | — | — | Increased — |
CAPITAL FUND MANAGEMENT S.A. manages $6.5B across 1500 positions as of Q1 2020. Top holdings: XOM calls (1.3%), SPY puts (1.2%), NFLX puts (1.2%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
Active quarter - 297 new positions, 337 exits, 253 increased. Top move: MRK (INCREASED, conviction 67). Portfolio: $6.5B across 1500 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR